Sykes And Ray Equities Open An Account Button
SRE India Mobile Trading App Download Promotion
Sykes And Ray Equities India Start SIP Investment Visual
Sykes And Ray Equities India Start Trading Online Visual

Markets

Market Nav

News Details

01/06/2026 11:40

Aarey Drugs&Pharma. Q4 net profit zooms 231.91% at Rs 1.56 cr

The company reported standalone net profit of Rs 1.56 crore for the quarter ended March 31, 2026 as compared to Rs 0.47 crore in the same period last year, registering a year-on-year growth of 231.91 per cent.

Net revenue of the company rose substantially by 75.27 per cent at Rs 189.47 crore in January-March quarter of this fiscal as against Rs 108.10 crore in the corresponding period last year.

During January-March quarter, operating expenses increased by 63.90 per cent to Rs 185.13 crore from Rs 112.95 crore in year ago period.

Other Income dipped by 105.70 per cent at Rs -0.43 crore versus (Mar'25 Rs 7.54 crore).

Operating Profit surged by 189.48 per cent to Rs 4.34 crore as against Rs -4.85 crore in the year ago period, while Operating Profit Margin (OPM) contracted year-on-year to 151.00 per cent in March quarter.

Interest declined by 28.23 per cent y-o-y to Rs 1.78 crore, while Taxation decreased by 124.35 per cent at Rs -0.28 crore (Mar'25 Rs 1.15 crore).